OverviewChartProfileKey statisticsFinancialsTechnicalNews
Derivatives
TraderScreen

Van Lanschot Kempen NV/  NL0000302636  /

Euronext - Amsterdam
2024-11-08  4:24:29 PM Chg. -0.100 Volume Bid4:25:09 PM Ask4:25:18 PM Market Capitalization Dividend Y. P/E Ratio
41.750EUR -0.24% 36,292
Turnover: 1.52 mill.		 41.700Bid Size: 3,329 41.800Ask Size: 795 1.77 bill.EUR 4.79% 14.81
GlobeNewswire 06-26 Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary share...
GlobeNewswire 06-25 Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900...
GlobeNewswire 06-25 Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 90...
GlobeNewswire 05-30 Merus Announces Pricing of Upsized Public Offering of Common Shares
GlobeNewswire 05-28 Merus N.V. Announces Proposed Public Offering of Common Shares
GlobeNewswire 04-05 ORYZON to Provide Corporate Progress Updates at Several Events in April
GlobeNewswire 04-04 Oculis to Participate at Upcoming April Investor Conferences
GlobeNewswire 04-03 Pharming Group to participate in April investor conferences
GlobeNewswire 03-18 Transgene Announces Upcoming Investor Meetings
GlobeNewswire 03-04 Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
GlobeNewswire 02-29 MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and...
GlobeNewswire 02-08 Autolus Announces Pricing of Underwritten Offering
GlobeNewswire 01-31 Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
GlobeNewswire 2023-12-22 Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank
GlobeNewswire 2023-10-10 Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
GlobeNewswire 2021-02-09 SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 22.5 MILLION IN AN EQUITY PLACEMENT
GlobeNewswire 2021-02-09 SEQUANA MEDICAL LAUNCHES EQUITY PLACEMENT
GlobeNewswire 2020-07-07 Mid-Stabilisation Period Announcement
GlobeNewswire 2020-06-26 Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public Offering
GlobeNewswire 2020-06-24 Hyloris Pharmaceuticals Announces Narrowing of Price Range of its Initial Public Offering
GlobeNewswire 2020-06-19 Hyloris Pharmaceuticals Announces Coverage of the Maximum Offering Size, including Increase Option a...
GlobeNewswire 2020-06-18 Hyloris Pharmaceuticals Announces the Coverage of the Base Offering Throughout the Price Range of it...
GlobeNewswire 2020-06-17 Hyloris Pharmaceuticals launches its Initial Public Offering on Euronext Brussels
GlobeNewswire 2020-06-03 Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussel...
GlobeNewswire 2020-01-22 Sequana Medical Successfully Raises Eur 19.0 Million in an Equity Placement